Amplia Therapeutics
(ASX) ATX
Amplia Therapeutics Financials at a Glance
Market Cap
$79.53M
Revenue (TTM)
$5.79M
Net Income (TTM)
$14.12M
EPS (TTM)
$-0.02
P/E Ratio
-7.71
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$0.15
Volume
4,374,883
Open
$0.17
Price
$0.15
Volume
4,374,883
Open
$0.17
Previous Close
$0.15
Daily Range
$0.15 - $0.17
52-Week Range
$0.05 - $0.42
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$0.15
Volume
4,374,883
Open
$0.17
Previous Close
$0.15
Daily Range
$0.15 - $0.17
52-Week Range
$0.05 - $0.42
ATX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amplia Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Christopher J. Burns, PhD
Website
www.ampliatx.comHeadquarters
Melbourne, VIC 3000, AU
ATX Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-5%
Net Income Margin
-3%
Return on Equity
-28%
Return on Capital
-25%
Return on Assets
-18%
Earnings Yield
-12.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$79.53M
Shares Outstanding
513.07M
Volume
4.37M
Short Interest
0.00%
Avg. Volume
3.96M
Financials (TTM)
Gross Profit
$3.57M
Operating Income
$6.52M
EBITDA
$6.78M
Operating Cash Flow
$6.89M
Capital Expenditure
$2.07K
Free Cash Flow
$6.89M
Cash & ST Invst.
$10.86M
Total Debt
$13.89K
Amplia Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$36.30K
-101.5%
Gross Margin
0.00%
N/A
Market Cap
$79.53M
N/A
Market Cap/Employee
$79.53M
N/A
Employees
1
N/A
Net Income
$4.18M
-269.9%
EBITDA
$6.77M
-94.0%
Quarterly Fundamentals
Net Cash
$28.78M
+742.2%
Accounts Receivable
$6.40M
+78.0%
Inventory
$0.00
N/A
Long Term Debt
$297.58K
+441.2%
Short Term Debt
$83.84K
-96.2%
Return on Assets
-17.81%
N/A
Return on Invested Capital
-24.88%
N/A
Free Cash Flow
$7.67M
-116.6%
Operating Cash Flow
$7.65M
-115.9%